Wednesday, January 14, 2026
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home Authors Posts by Editor / Curator

Editor / Curator

Editor / Curator
1026 POSTS 0 COMMENTS
Mitesco, Biotech Stock Review
Incubator

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter...

Editor / Curator -
IPOS

Going Public. Direct Listing Update, (Anthony L.G., PLLC)

Editor / Curator -
Uncategorized

Going Public Guide (PWC).

Editor / Curator -
Biotech News

Hapbee Corporate Presentation. Private.

Editor / Curator -
Biotech News

Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More...

Editor / Curator -
All News

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly...

Editor / Curator -
All News

Apple’s Second Chance at Romance. One That Got Away, Twice!

Editor / Curator -
Julie R Smith, True Nature, Mitesco
Interview

True Nature|Mitesco President & COO, Julie Smith Interview.

Editor / Curator -
Biotech News

True Nature|Mitesco (TNTY). Coverage Report Issued.

Editor / Curator -
steven boyd, biotech stock review
Biotech News

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

Editor / Curator -
1...838485...103Page 84 of 103

Latest article

Y-Combinator | Top 10 Performing Portfolio Holdings

All News Editor / Curator -
Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, has incredibly been used to...

Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.

2025 Watch List Editor / Curator -
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...

Sekur Private Data (SKUR, SWISF) Inching Towards a Double!

Uncategorized Editor / Curator -
Sekur Private Data has been slowly working it's way higher, on a series of positive news events. Here are the headlines and short to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.